Copyright ¬© APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.

Our platform integrates distinct technology areas into a powerful engine for therapeutic candidate generation and product development.

Intestinal Biology

Constructs for Selective Access

Directed Targets

Development & CMC

Molecule Engineering & Pharmacology

Safety Toxicology

Bio-analytical

Receptor Proteomics

Process Development

PKDM

Oral Dosage Forms

Linkers

Cell & Tissue Targeting

Protein Engineering

Screening

Microbial Genomics

Protein ‚ÄčFormulation

TECHNOLOGIES AND PIPELINE

Our proprietary translocation technology, TRANSINT, uses microbe-inspired scaffold design to engineer proteins capable of overcoming gastrointestinal epithelial barriers to achieve best-in-class biopharmaceutical transport efficiency and selective cell targeting. We are focusing on high value opportunities with superior pharmacological benefits due to the oral-GI route of administration. Our development pipeline has been carefully selected and is fueled by novel technologies for constructing, robustly validating, and developing therapeutic candidates to the clinic.



Applied Molecular Transport's unique product strategy is a result of novel insights into:

Overview